{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:14:31Z","timestamp":1792728871040,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"vor","delay-in-days":6154,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1111\/j.1538-7836.2006.01703.x","type":"journal-article","created":{"date-parts":[[2006,1,13]],"date-time":"2006-01-13T08:54:47Z","timestamp":1137142487000},"page":"403-410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["Murine model of ferric chloride\u2010induced vena cava thrombosis: evidence for effect of potato carboxypeptidase inhibitor"],"prefix":"10.1016","volume":"4","author":[{"given":"X.","family":"WANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.L.","family":"SMITH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.Y.","family":"HSU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"OGLETREE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.A.","family":"SCHUMACHER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0010","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1046\/j.1538-7836.2003.00329.x","article-title":"Thrombin\u2010activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U)","volume":"1","author":"Bouma","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0015","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.2174\/0929867043364586","article-title":"Thrombin\u2010activatable fibrinolysis inhibitor","volume":"11","author":"Marx","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0020","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1055\/s-0037-1615366","article-title":"Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation","volume":"80","author":"Mosnier","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0025","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1182\/blood.V95.9.2855.009k02_2855_2859","article-title":"Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis","volume":"95","author":"Van Tilburg","year":"2000","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0030","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1055\/s-0037-1613349","article-title":"Thrombin activatable fibrinolysis inhibitor (TAFI) levels in patients with coronary artery disease investigated by angiography","volume":"88","author":"Schroeder","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0035","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1046\/j.1365-2141.2003.04549.x","article-title":"Thrombin\u2010activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system","volume":"122","author":"Zorio","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0040","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1161\/01.STR.0000063139.06585.45","article-title":"Thrombin\u2010activable fibrinolysis inhibitor levels in the acute phase of ischemic stroke","volume":"34","author":"Montaner","year":"2003","journal-title":"Stroke"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0045","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1172\/JCI118315","article-title":"Plasma carboxypeptidases as regulators of the plasminogen system","volume":"96","author":"Redlitz","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0050","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1016\/S0021-9258(20)79755-3","article-title":"Purification and properties of a carboxypeptidase inhibitor from potatoes","volume":"249","author":"Ryan","year":"1974","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0055","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1172\/JCI781","article-title":"Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti\u2010fibrinolytic factor","volume":"101","author":"Minnema","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0060","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0014-2999(03)01297-4","article-title":"Carboxypeptidase B inhibitors reduce tissue factor\u2010induced renal microthrombi in rats","volume":"461","author":"Muto","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0065","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1124\/jpet.103.062729","article-title":"Enhancement of fibrinolysis by EF6265 [(S)\u20107\u2010amino\u20102\u2010[[[(R)\u20102\u2010methyl\u20101\u2010(3\u2010phenylpropanoylamino)propyl]hydroxyphosphinoyl] methyl]heptanoic acid], a specific inhibitor of plasma carboxypeptidase B","volume":"309","author":"Suzuki","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0070","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1021\/jm034141y","article-title":"Synthesis and evaluation of imidazole acetic acid inhibitors of activated thrombin\u2010activatable fibrinolysis inhibitor as novel antithrombotics","volume":"46","author":"Barrow","year":"2003","journal-title":"J Med Chem"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0075","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1172\/JCI0212119","article-title":"Thrombin\u2010activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life","volume":"109","author":"Nagashima","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0080","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1172\/JCI0215082","article-title":"In vivo regulation of plasminogen function by plasma carboxypeptidase B","volume":"110","author":"Swaisgood","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0085","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1538-7836.2005.01236.x","article-title":"Effects of factor IX or factor XI deficiency on ferric chloride\u2010induced carotid artery occlusion in mice","volume":"3","author":"Wang","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0090","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00001721-200112000-00003","article-title":"Disintegration and reorganization of fibrin networks during tissue\u2010type plasminogen activator\u2010induced clot lysis","volume":"12","author":"Meh","year":"2001","journal-title":"Blood Coag Fibrinolysis"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0003-2697(84)90357-9","article-title":"Streptomyces R61 DD\u2010carboxypeptidase: hydrolysis of X\u2010D\u2010alanyl\u2010D\u2010alanine peptides measured by a fluorometric assay","volume":"137","author":"Georgopapadakou","year":"1984","journal-title":"Anal Biochem"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0100","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1021\/ed081p398","article-title":"96\u2010well plate colorimetric assay for Ki determination of (\u00b1)\u20102\u2010benzylsuccinic acid, an inhibitor of carboxypeptidase A: a laboratory experiment in drug discovery","volume":"81","author":"Wentland","year":"2004","journal-title":"J Chem Educ"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0105","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0049-3848(90)90106-M","article-title":"Rat model of arterial thrombosis induced by ferric chloride","volume":"60","author":"Kurz","year":"1990","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0110","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1055\/s-0037-1613739","article-title":"Murine thrombosis models","volume":"92","author":"Day","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0115","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/01.mbc.0000169216.70184.8d","article-title":"The effects of ximelagatran and warfarin on the prophylaxis of a caval vein thrombosis and bleeding in the anaesthetized rat","volume":"16","author":"Carlsson","year":"2005","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0120","doi-asserted-by":"crossref","first-page":"9524","DOI":"10.1073\/pnas.95.16.9524","article-title":"A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis","volume":"95","author":"Denis","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0049-3848(98)00213-8","article-title":"Antithrombotic effects and bleeding time of thrombin inhibitors and warfarin in the rat","volume":"94","author":"Elg","year":"1999","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0130","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1182\/blood.V98.4.1055","article-title":"Variable protection of \u03b23\u2010integrin\u2010deficient mice from thrombosis initiated by different mechanisms","volume":"98","author":"Smyth","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0135","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1182\/blood-2002-05-1470","article-title":"Protection against thrombosis in mice lacking PAR3","volume":"100","author":"Weiss","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0140","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1001\/archinte.1996.00440140067006","article-title":"The effectiveness of implementing the weight\u2010based heparin nomogram as a practice guideline","volume":"156","author":"Raschke","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0145","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel vs. aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0150","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1182\/blood.V80.9.2281.bloodjournal8092281","article-title":"Importance of platelets in experimental venous thrombosis in the rat","volume":"80","author":"Herbert","year":"1992","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0155","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0049-3848(87)90166-6","article-title":"A new experimental model of venous thrombosis in rats involving partial stasis and slight endothelium alterations","volume":"45","author":"Millet","year":"1987","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0160","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1161\/01.STR.0000049765.81774.A3","article-title":"Inhibition of factor Xa reduces ischemic brain damage after thromboembolic stroke in rats","volume":"34","author":"Wang","year":"2003","journal-title":"Stroke"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0165","doi-asserted-by":"crossref","first-page":"8913","DOI":"10.1074\/jbc.M205006200","article-title":"Stabilization vs. inhibition of TAFIa by competitive inhibitors in vitro","volume":"278","author":"Walker","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0170","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1538-7836.2003.00028.x","article-title":"Reversible inhibitors of TAFIa can both promote and inhibit fibrinolysis","volume":"1","author":"Schneider","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.01703.x_bb0175","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1182\/blood.V94.8.2735.420k30_2735_2743","article-title":"A novel approach to arterial thrombolysis","volume":"94","author":"Klement","year":"1999","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2006.01703.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622121215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622121215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2006.01703.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:36:53Z","timestamp":1761532613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622121215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S1538783622121215"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2006.01703.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Murine model of ferric chloride\u2010induced vena cava thrombosis: evidence for effect of potato carboxypeptidase inhibitor","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2006.01703.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}